Change language
Besuchen Sie uns auf den sozialen Netzwerken
Homepage  →  Neuigkeiten

Evenswiss was present last week at CCR London

Evenswiss was present last week at CCR London. CCR London connected the surgical and non-surgical medical aesthetics specialties and CCR has quickly become the UK’s leading educational event, delivering free CPD certified conferences covering both surgical and non-surgical procedures. With over 130 exhibitors, we were one together with our fabulous Evenswiss UK- team. Evenswiss and our unique patent Dermatopoietin took great steps towards deeper awareness and recognition in this field.

Evenswiss is so proud to be selected in CCR London as Innovation Trial 2022!

The Medical Aesthetic community and committee was inspired by the innovation and technology of Dermatopoietin.

We are very happy that our technology efforts and forward-thinking vision is on this stage and at such an important point.

Für weitere News klicken Sie hier

News und Events

27 März 2024

EVENSWISS at Cosmoprof Bologna 2024 Edition

On behalf of the entire Evenswiss team, we extend our warmest thanks to each and every one of you who honored the stand with your presence at Cosmoprof Bologna.

13 Februar 2024

Unlocking the Secrets of Skin Rejuvenation: A Recap of the EVENSWISS Seminars in Latvia and Lithuania with our official exclusive distributor Klinika AMELA

Recently, skincare professionals in Latvia and Lithuania had the exclusive opportunity to dive deeper into the world of skincare rejuvenation at the EVENSWISS x Klinika AMELA Seminars.

26 Dezember 2023

Celebrating a Year of Unforgettable Milestones with EVENSWISS - Our year in a nutshell

As we reflect on the incredible journey of the past year, we are deeply grateful for the milestones that have highlighted EVENSWISS's path.

26 November 2023

Successful Cosmoprof Asia Hong Kong 2023

We, EVENSWISS, had a successful week in Hong Kong in many ways. Constantly growing interest and demand in the Asian market is a true thing and one of the biggest key points for us. Needless to say, thanks to our unique products with Dermatopoietin, again gathered a huge amount of interest.